The company will be featuring its sustainable packaging solutions at the event in Paris on Jan. 22–23, 2025.

A Four-Phased Approach for Evaluating a Quality Risk Management Activity ...

This paper explores the legal and regulatory framework around 3D drug printing, particularly for personalized medicine, considering regulatory compliance, business concerns, and intellectual property ...

Vanessa Almendro, Elliot Berger, Benjamin McCloud, and Turna Ray go behind the headlines to discuss 2024’s biggest trends in the pharmaceutical industry, as well as the unforeseen outcomes that took ...

SEKISUI has used a £15.7 million (US$20.7 million) investment to expand its clinical-grade drug substance manufacturing at its UK site. Financing from OrbiMed, Novo Holdings, Jeito Capital, and others ...